FeesSafety
Pluang+

J & J Snack Foods Q4 sales dip 1% but net earnings jump 195% on cost savings and margin gains

Company Fundamentals
18 Nov 2026, 14:00 WIB
GlobeNewsWire
View Source
Bullish
J & J Snack Foods Q4 sales dip 1% but net earnings jump 195% on cost savings and margin gains

J & J Snack Foods reported a 1% decline in Q4 net sales to $406 million but saw net earnings surge 195% to $33.6 million, driven by $25 million in annualized savings from Project Apollo and a 200 basis point gross margin expansion. Despite a 21.6% rise in distribution costs due to higher freight and fuel, adjusted EBITDA reached $53.3 million. Food Service sales fell 7.4%, offset by 17.1% growth in Retail and 6.1% in Frozen Beverages. The company expects to return to sales growth in fiscal 2027, supported by innovation, pricing, and further cost efficiencies.

J & J Snack Foods' fiscal 2026 Q4 results provide context for consumer staples market activity. For readers following Consumer Staples, here is Pluang's market snapshot as of Nov 18, 2026 19:11 WIB: Out of 62 priced US stocks, 6 rose and 49 fell. Notable movers include DEO (Diageo plc) at USD 99.28 with a -1.44% change, LW (Lamb Weston Holdings Inc) at USD 53.47 with a -1.29% change and 100% buy order activity, and DNUT (Krispy Kreme Inc) at USD 3.54 with a -1.12% change and 100% buy order activity.

More News

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
49 minutes ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
55 minutes ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgraded Charles Schwab to Strong Buy following strong growth in October 2026. Client assets rose 12% year over year to $13.27 trillion, with core net new assets surging 50% to $66.5 billion, a record for the month. Schwab also opened 4...

Analyst Insights
Bullish
2 hours ago
SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse, a B2B automotive software marketplace founded by General Motors, Magna, and Wipro, was honored with a CES Innovation Award 2027 in the Enterprise Tech category. The platform uses AI and standardized technical data to help automakers and supp...

Others
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App